Siraj Ali
Overview
Explore the profile of Siraj Ali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
2022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Khiabanian H, Hirshfield K, Goldfinger M, Bird S, Stein M, Aisner J, et al.
JCO Precis Oncol
. 2018 Sep;
2018.
PMID: 30246169
Purpose: Inherited germline defects are implicated in up to 10% of human tumors, with particularly well-known roles in breast and ovarian cancers that harbor -mutated genes. There is also increasing...
12.
Panda A, Betigeri A, Subramanian K, Ross J, Pavlick D, Ali S, et al.
JCO Precis Oncol
. 2018 Jun;
2017.
PMID: 29951597
Purpose: An association between mutational burden and response to immune checkpoint therapy has been documented in several cancer types. The potential for such a mutational burden threshold to predict response...
13.
Taylor J, Pavlick D, Yoshimi A, Marcelus C, Chung S, Hechtman J, et al.
J Clin Invest
. 2018 Jun;
128(9):3819-3825.
PMID: 29920189
Rearrangements involving the neurotrophic receptor kinase genes (NTRK1, NTRK2, and NTRK3; hereafter referred to as TRK) produce oncogenic fusions in a wide variety of cancers in adults and children. Although...
14.
Yin M, Grivas P, Emamekhoo H, Mendiratta P, Ali S, Hsu J, et al.
Oncotarget
. 2018 Apr;
9(24):16891-16898.
PMID: 29682192
Background: Mutations of DNA repair genes, e.g. , are frequently found in urothelial cancer (UC) and have been associated with better response to cisplatin-based chemotherapy. Further external validation of the...
15.
Severson E, Riedlinger G, Connelly C, Vergilio J, Goldfinger M, Ramkissoon S, et al.
Blood
. 2018 Apr;
131(22):2501-2505.
PMID: 29678827
No abstract available.
16.
Morgan G, He J, Tytarenko R, Patel P, Stephens O, Zhong S, et al.
Leukemia
. 2018 Apr;
32(11):2435-2444.
PMID: 29654269
Chromosomal rearrangements that result in oncogenic kinase activation are present in many solid and hematological malignancies, but none have been reported in multiple myeloma (MM). Here we analyzed 1421 samples...
17.
Nagy A, Bhaduri A, Shahmarvand N, Shahryari J, Zehnder J, Warnke R, et al.
Blood Adv
. 2018 Mar;
2(5):481-491.
PMID: 29496669
Castleman disease (CD) is a rare lymphoproliferative disorder subclassified as unicentric CD (UCD) or multicentric CD (MCD) based on clinical features and the distribution of enlarged lymph nodes with characteristic...
18.
Landman Y, Ilouze M, Wein S, Neiman V, Yerushalmi R, Yakimov M, et al.
Clin Breast Cancer
. 2017 Dec;
18(3):e267-e270.
PMID: 29233640
No abstract available.
19.
Panda A, Mehnert J, Hirshfield K, Riedlinger G, Damare S, Saunders T, et al.
J Natl Cancer Inst
. 2017 Nov;
110(3):316-320.
PMID: 29155997
Response to immune checkpoint therapy can be associated with a high mutation burden, but other mechanisms are also likely to be important. We identified a patient with metastatic gastric cancer...
20.
Wang V, Urisman A, Albacker L, Ali S, Miller V, Aggarwal R, et al.
J Immunother Cancer
. 2017 Sep;
5(1):75.
PMID: 28923100
Background: Large cell neuroendocrine tumor (LCNEC) of the lung is a rare and aggressive tumor similar to small cell lung cancer (SCLC). Thus, it is often treated similarly to SCLC...